AR035809A1 - Cromosomas artificiales que comprenden secuencias de ehv - Google Patents

Cromosomas artificiales que comprenden secuencias de ehv

Info

Publication number
AR035809A1
AR035809A1 ARP020101221A AR035809A1 AR 035809 A1 AR035809 A1 AR 035809A1 AR P020101221 A ARP020101221 A AR P020101221A AR 035809 A1 AR035809 A1 AR 035809A1
Authority
AR
Argentina
Prior art keywords
ehv
generation
virus
artificial chromosome
chromosome vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Suspension/Interruption
Application number
Other languages
English (en)
Spanish (es)
Inventor
Nikolaus Osterrieder
Jens Rudolph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AR035809A1 publication Critical patent/AR035809A1/es
Suspension/Interruption legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP020101221 2001-04-03 2002-04-03 Cromosomas artificiales que comprenden secuencias de ehv Suspension/Interruption AR035809A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2001116594 DE10116594A1 (de) 2001-04-03 2001-04-03 Künstliche Chromosomen, die EHV-Sequenzen umfassen

Publications (1)

Publication Number Publication Date
AR035809A1 true AR035809A1 (es) 2004-07-14

Family

ID=7680223

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101221 Suspension/Interruption AR035809A1 (es) 2001-04-03 2002-04-03 Cromosomas artificiales que comprenden secuencias de ehv

Country Status (7)

Country Link
EP (1) EP1377668A2 (ja)
JP (1) JP2004531254A (ja)
AR (1) AR035809A1 (ja)
CA (1) CA2443039A1 (ja)
DE (1) DE10116594A1 (ja)
MX (1) MXPA03008971A (ja)
WO (1) WO2002081712A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080226677A1 (en) * 2004-05-06 2008-09-18 Yasuko Mori Recombinant virus vector for gene transfer into lymphoid cells
SG11201405847SA (en) * 2012-03-20 2014-10-30 Merial Inc Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
KR102618843B1 (ko) * 2016-09-20 2024-01-02 베링거잉겔하임베트메디카게엠베하 신규한 ehv 삽입 부위 orf70

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193983B1 (en) * 1992-06-01 2001-02-27 The University Of Melbourne Equine herpesvirus glycoproteins

Also Published As

Publication number Publication date
EP1377668A2 (en) 2004-01-07
CA2443039A1 (en) 2002-10-17
WO2002081712A2 (en) 2002-10-17
JP2004531254A (ja) 2004-10-14
WO2002081712A3 (en) 2003-10-02
MXPA03008971A (es) 2004-02-12
DE10116594A1 (de) 2002-10-10

Similar Documents

Publication Publication Date Title
ES2750960T3 (es) Vacuna de virus de la fiebre porcina africana atenuado
RU2541784C2 (ru) Лиофилизированная композиция для индукции иммунного ответа на флавивирус, композиция и способ для ее получения
MY197376A (en) A rationally oeveloped afrigan swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 tsolate
NO20052136L (no) Vaksine mot Hepatitt C-virus (HCV).
MX2020000221A (es) Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas.
Wang et al. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant
Medaglia et al. Genomic analysis, phenotype, and virulence of the historical Brazilian smallpox vaccine strain IOC: implications for the origins and evolutionary relationships of vaccinia virus
Thiry et al. Recombination in the alphaherpesvirus bovine herpesvirus 1
Chowdhury et al. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge
PE20140871A1 (es) COMPOSICIONES Y METODOS DE VACUNA DEL VIRUS TIPO 1b DE DIARREA VIRAL BOVINA
HUP0303431A2 (hu) PRRS vírus élő legyengített törzsei
JP2018527885A (ja) 核酸含有組成物の作製および精製のためのプロセス
Zhang et al. Immune evasive effects of SARS-CoV-2 variants to COVID-19 emergency used vaccines
Luo et al. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine
Zhu et al. Construction of an attenuated goatpox virus AV41 strain by deleting the TK gene and ORF8-18
Zhang et al. Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain
Liu et al. Development of recombinant goatpox virus expressing Echinococcus granulosus EG95 vaccine antigen
Vilček et al. Cellular insertions in the NS2-3 genome region of cytopathic bovine viral diarrhoea virus (BVDV) isolates
CO2017005830A2 (es) Composiciones de vacuna para el virus del dengue
AR035809A1 (es) Cromosomas artificiales que comprenden secuencias de ehv
MX2022016287A (es) Secuencias de acidos nucleicos y de aminoacidos de adenovirus de gorila, vectores que contienen las mismas y usos de las mismas.
Li et al. Generation of an attenuated Tiantan vaccinia virus strain by deletion of multiple genes
Kan et al. Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes
AU2017268710A1 (en) Arthrogenic alphavirus vaccine
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine

Legal Events

Date Code Title Description
FB Suspension of granting procedure